PubMed Journals Articles About "Late John Mendlein Joins Reinventing Biotech Lineup April" RSS

01:48 EDT 2nd July 2016 | BioPortfolio

Late John Mendlein Joins Reinventing Biotech Lineup April PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Late John Mendlein Joins Reinventing Biotech Lineup April articles that have been published worldwide.

More Information about "Late John Mendlein Joins Reinventing Biotech Lineup April" on BioPortfolio

We have published hundreds of Late John Mendlein Joins Reinventing Biotech Lineup April news stories on BioPortfolio along with dozens of Late John Mendlein Joins Reinventing Biotech Lineup April Clinical Trials and PubMed Articles about Late John Mendlein Joins Reinventing Biotech Lineup April for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Late John Mendlein Joins Reinventing Biotech Lineup April Companies in our database. You can also find out about relevant Late John Mendlein Joins Reinventing Biotech Lineup April Drugs and Medications on this site too.

Showing "Late John Mendlein Joins Reinventing Biotech Lineup April" PubMed Articles 1–25 of 3,100+

Neuro-oncology biotech industry progress report.

The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015. The focus was once again on fostering collaboration between neuro-oncologist, neurosurgeons, scientists, leaders from biotechnology and pharmaceutical industries, and members of the financial community. The summit highlighted the recent advances in the treatment of brain tumor, and specifically focused on tar...

Chronic myeloid leukemia: reminiscences and dreams.

With the deaths of Janet Rowley and John Goldman in December 2013, the world lost two pioneers in the field of chronic myeloid leukemia. In 1973, Janet Rowley, unraveled the cytogenetic anatomy of the Philadelphia chromosome, which subsequently led to the identification of the BCR-ABL1 fusion gene and its principal pathogenetic role in the development of chronic myeloid leukemia. This work was also of major importance to support the idea that cytogenetic changes were drivers of leukemogenesis. John Goldman ...

Reinventing nonpatent literature for pharmaceutical patenting.

Bayer joins CRISPR.

The Clearer BENEFITS of Belatacept.

"In the long run," the economist John Maynard Keynes wryly observed in his 1923 A Tract on Monetary Reform, "we are all dead." Given the logistic barriers to performing long-term studies of immunosuppression in kidney-transplant recipients, as well as the associated expense, many transplant professionals are similarly pessimistic about how to determine adequate long-term regimens in the current era, in which short-term results are excellent but late transplant loss remains a vexing problem. More than 14,000...

The Novel New Jersey Eyewitness Instruction Induces Skepticism but Not Sensitivity.

In recent decades, social scientists have shown that the reliability of eyewitness identifications is much worse than laypersons tend to believe. Although courts have only recently begun to react to this evidence, the New Jersey judiciary has reformed its jury instructions to notify jurors about the frailties of human memory, the potential for lineup administrators to nudge witnesses towards suspects that they police have already identified, and the advantages of alternative lineup procedures, including bli...

Erratum: When biotech goes bad.

First-quarter biotech job picture.

1Q16-the biotech bear growls.

UK biotech smashes financing record.

Fourth-quarter biotech job picture.

Fresh from the biotech pipeline-2015.

2015-another banner year for biotech.

Revamp biotech rules, says White House.

Trade-sale exits in different biotech sectors.

A face-lift for biotech rules begins.

Reflection for Nursing Life: Principles, Process and Practice McKinnon John Reflection for Nursing Life: Principles, Process and Practice 138pp £25.99 Routledge 9781138757599 1138787590 Formula: see text.

Reflection is a key part of life as a nurse, and even more so since the Nursing and Midwifery Council introduced the revalidation process in April.

IBM debuts hyped 'cognitive cloud' biotech HQ in Cambridge.

Biotech's wellspring-a survey of the health of the private sector in 2015.

Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes.

Diabetes mellitus is a chronic disease that affects over 382 million people worldwide. Type-1 Diabetes (T1D) is classified as an autoimmune disease that results from pancreatic β-cell destruction and insulin deficiency. Type-2 Diabetes (T2D) is characterized principally by insulin resistance in target tissues followed by decreased insulin production due to β-cell failure. It is challenging to identify immunological markers such as inflammatory molecules that are triggered in response to changes during the...

Attraction of the Invasive Halyomorpha halys (Hemiptera: Pentatomidae) to Traps Baited with Semiochemical Stimuli Across the United States.

A recent identification of the two-component aggregation pheromone of the invasive stink bug species, Halyomorpha halys (Stål), in association with a synergist, has greatly improved the ability to accurately monitor the seasonal abundance and distribution of this destructive pest. We evaluated the attraction of H. halys to black pyramid traps baited with lures containing the pheromone alone, the synergist methyl (2E,4E,6Z)-decatrienoate (MDT) alone, and the two lures in combination. Traps were deployed aro...

Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy.

A proliferation-inducing ligand (APRIL) is a member of the tumor necrosis factor (TNF) superfamily. Despite advances in clinical and genetic studies, the details of the pathological roles of APRIL in IgA nephropathy (IgAN) remain to be fully defined. The present study aimed to further assess the pathological role of APRIL using a mouse model of IgAN. Mice with IgAN designated "grouped ddY" (gddY) were intraperitoneally administered an anti-APRIL monoclonal antibody (anti-APRIL Ab) or control IgG (Control Ab...

There and Back Again: Mitchell Finer on the Journey of Biotech from Start-Up to Success.

Phosphoinositide regulation of TRPM channels - TRPM3 joins the club!

Biosimilars in India.

Biosimilars have been defined as biotech drugs that have been shown to have comparable quality, safety and efficacy to the original product. The past decade has seen a significant increase in interest in these products from the biotech industry. Major developments have occurred with respect to establishing a regulatory path for approval of these products as well as in our understanding of how the different quality attributes of a biosimilar impact its safety and efficacy. India is globally regarded to have ...

Quick Search